
Scintimun® Commercialization Partnership with Curium Pharma
MELBOURNE,Australiaand LIÈGE,Belgium,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX,Telix,the Company) today announces that it has entered into an agreement with Curium Ph